Roy Harper

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 4.8K citations

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 1.4K citations

Hypertension, Pharmacotherapy, Blood Pressure +16

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Feature selection and classification model construction on type 2 diabetic patients’ data

Yue Huang, Paul McCullagh, N.D. Black et al. · Artificial Intelligence in Medicine · 2007 · 170 citations

Diabetes Management, Engineering, Data Science +9